The three-dimensional structure of human bactericidal/permeability-increasing protein: Implications for understanding protein–lipopolysaccharide interactions
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 57 (3) , 225-229
- https://doi.org/10.1016/s0006-2952(98)00279-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The BPI/LBP family of proteins: A structural analysis of conserved regionsProtein Science, 1998
- Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsisThe Lancet, 1997
- Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.Journal of Clinical Investigation, 1997
- Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing ProteinJournal of Biological Chemistry, 1997
- Lipopolysaccharide‐binding protein mediates CD14‐independent intercalation of lipopolysaccharide into phospholipid membranesFEBS Letters, 1996
- Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing ProteinThe Journal of Infectious Diseases, 1995
- Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.The Journal of Experimental Medicine, 1994
- Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.The Journal of Experimental Medicine, 1994
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- BIOCHEMISTRY OF ENDOTOXINSAnnual Review of Biochemistry, 1990